Reaction

Cell Death reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,962 reports · 69 co-occurring drugs

As of the last recalculation, Cell Death appears in 1,962 FAERS reports alongside 69 co-occurring drug terms. The strongest observed disproportionality signal is FAM-TRASTUZUMAB DERUXTECAN-NXKI (PRR 28.8).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Fam-Trastuzumab Deruxtecan-Nxki	27	28.8	28.9
Amoxicillin And Clavulanate Potassium	49	19.6	19.6
Acetylcysteine	14	15.9	15.9
Posaconazole	22	14.5	14.5
Everolimus Tablets	20	12.8	12.8
Piperacillin Sodium,Tazobactam Sodium	28	11.3	11.4
Micafungin Sodium	9	11.3	11.3
Encorafenib	10	10.8	10.8
Enoxaparin Sodium	54	10.2	10.2
Atazanavir	13	9.7	9.7
Ritonavir	26	9.6	9.6
Esomeprazole	54	9.5	9.5
Daptomycin	8	9.2	9.2
Regorafenib	10	9.2	9.2
Pazopanib Hydrochloride	23	9.1	9.1
Posaconazole Delayed-Release	9	8.7	8.7
Lopinavir And Ritonavir	11	8.7	8.7
Darunavir	12	8.5	8.5
Midazolam Hydrochloride	21	8.4	8.4
Piperacillin And Tazobactam	10	8.3	8.3
Entecavir	9	8.2	8.2
Basiliximab	9	8.2	8.2
Midazolam	19	8.1	8.1
Anti-Thymocyte Globulin (Rabbit)	6	7.9	7.9
Sulfamethoxazole And Trimethoprim	60	7.8	7.8
Heparin Sodium	10	7.7	7.8
Rifampin	10	7.3	7.3
Ribociclib	21	7.1	7.1
Voriconazole	20	7.0	7.1
Norepinephrine	7	7.0	7.0
Cabozantinib	31	6.9	6.9
Ethyl Alcohol	17	6.7	6.7
Isoniazid	10	6.6	6.6
Abacavir Sulfate	6	6.6	6.6
Valproic Acid	18	6.1	6.1
Imatinib	10	6.0	6.0
Gemcitabine	22	6.0	6.0
Vismodegib	5	6.0	6.0
Oxazepam	12	6.0	6.0
Pyrazinamide	5	5.7	5.7
Emtricitabine And Tenofovir Disoproxil Fumarate	24	5.6	5.6
Alcohol	20	5.5	5.5
Everolimus	26	5.5	5.5
Vincristine Sulfate	15	5.5	5.5
Gemcitabine Hydrochloride	27	5.5	5.5
Isopropyl Alcohol	17	5.4	5.4
Trametinib	12	5.3	5.3
Paclitaxel (Aibumin-Bound)	40	5.2	5.3
Pegaspargase	6	5.2	5.2
Brentuximab Vedotin	5	5.2	5.2
Blinatumomab	5	5.1	5.1
Dabrafenib	10	5.1	5.1
Ado-Trastuzumab Emtansine	4	5.0	5.0
Crizotinib	6	5.0	5.0
Ipilimumab	20	5.0	5.0
Pembrolizumab	46	4.7	4.7
Paclitaxel	43	4.7	4.7
Nivolumab	39	4.3	4.3
Pemetrexed Disodium	15	4.2	4.2
Durvalumab	8	4.2	4.2
Derma Foam Excel Hand Sanitizer	3	4.0	4.0
Ethanol	3	4.0	4.0
Atezolizumab	13	3.6	3.6
Vemurafenib	4	3.5	3.5
Romiplostim	5	3.5	3.5
Acalabrutinib	4	3.5	3.5
Venetoclax	18	3.1	3.1
Trifluridine And Tipiracil	3	3.0	3.0
Ixazomib	7	2.6	2.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.